Healthcare Pharmaceutical Biotech

CV Sciences, Inc. to Announce Second Quarter 2026 Results on August 13, 2026

August 10, 2026 8:00 PM

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced that it will release financial results for the second quarter ended June 30, 2026, after the stock market closes on Thursday, August 13, 2026. The Company will hold a conference call with the investment community...

Read more

MMJ Challenges Washington's "No Product" Cannabinoid Narrative as Dr. Oz Endorses Unvalidated CMS Hemp Products

August 10, 2026 6:40 PM

MMJ International Holdings, Inc. ("MMJ") today responded to a recurring and consequential mischaracterization of its pharmaceutical development program: the suggestion that MMJ has "no product." That characterization confuses regulatory authorization with physical reality. MMJ has a product. It has been formulated. It has been manufactured. It has been packaged. It has undergone analytical and stability work. What MMJ does not have is...

Read more

Value Drug Company Ready to Support Independent Pharmacies Seeking a New Wholesale Distribution Partner

August 10, 2026 9:40 AM

Value Drug Company, a pharmacist-led full-line wholesale distributor serving independent community pharmacies, announced today that it is prepared to support pharmacy owners evaluating new wholesale distribution arrangements following Smith Drug Company's recently announced operational transition. Value Drug Company is ready to work directly with affected independent pharmacy owners to evaluate their purchasing, distribution and operational...

Read more

MDCE Targets $5 Trillion Global Agriculture Market with StrainScan Pro Enterprise Deployment on iPad Air (OTC Pink:MDCE)

August 10, 2026 9:17 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) today highlighted the expansion of its StrainScan Pro platform into agricultural quality control, positioning the proprietary AI vision software for enterprise deployment on iPad Air devices across farming and post-harvest operations. Global agricultural production represents one of the world's largest economic sectors, with production value measured in the multi-trillion-dollar range and estimated...

Read more

Phase 1 Equity Announces Its Fourth Practice Addition of the Year, Welcoming a Multi-Site Orthodontic Practice Located in North Dakota, Marking the Platform's 23rd Doctor and 33rd Location

August 10, 2026 9:00 AM

Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for orthodontists and pediatric dentists, today announced the addition of a multi-site orthodontic practice based in North Dakota to its growing network. The practice is known for delivering highly personalized, relationship-driven care in a warm, family-friendly setting, supported by an experienced clinical team and modern orthodontic techniques. This partnership marks...

Read more

From Molecule to Market: Life Sciences AI Enters Governed Production

August 10, 2026 9:00 AM

Black Book Research today published the 2026-2027 Life Sciences AI Technology Performance Benchmark, developed with research partner and contributing author Applied Artificial Intelligence LLC. Based on 1,277 verified buyers, scientific and operational leaders, technical evaluators and direct users, the independent study evaluates 254 market participants across 28 categories and scorecards. The benchmark spans the molecule-to-market lifecycle,...

Read more

Paradigm Treatment Receives State Approval to Add Eight Beds at Its Austin Teen Residential Treatment Center

August 10, 2026 9:00 AM

Paradigm Treatment, part of the Altior Healthcare network, has received state licensing approval to increase capacity at its Austin, Texas residential treatment center from 24 to 32 beds. This first phase of expansion adds eight new beds to help meet the growing demand for adolescent residential mental health services across Texas. Construction is also underway on a second expansion phase that will add an additional eight beds, bringing the...

Read more

Aspire Biopharma Completes Acquisition of Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue

August 10, 2026 8:30 AM

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), today announced that, the Company has completed its previously announced acquisition (the "Acquisition") of Dura Driver Control Systems ("DCS"), a tier-one supplier specializing in automotive systems that facilitate electronic driver control and the migration toward vehicle electrification, safety, lightweighting, and sustainability. The acquisition is expected to enhance...

Read more

NanoViricides Has Received Regulatory Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo To Fight the Current Largest Ever and Expanding Ebola Outbreak

August 10, 2026 8:30 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, announces that it has received regulatory approval to begin a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for the Current Bundibugyo Ebolavirus and other Ebola viruses, from the local regulatory agency ACOREP in the Democratic Republic of Congo (DRC). NanoViricides has retained Om Sai Clinical...

Read more

ABL Ascend Advanced Therapies Names Suman Subramanian as Chief Business Officer

August 10, 2026 4:00 AM

ABL Inc and Ascend Advanced Therapies today announced the appointment of Suman Subramanian as Chief Business Officer (CBO), further strengthening the Company's commercial leadership and its commitment to supporting customers with the development and manufacturing of viral vectors, vaccines, biologics and advanced therapies. Suman brings nearly two decades of experience and leadership, supporting emerging biotech and large pharma within the...

Read more

Black Book: Australia's 2027 Health IT Market Shifts From Pilots to Proof

August 9, 2026 9:40 PM

Black Book Research today announced the publication of its Australia & New Zealand Healthcare Information Technology: 2027 Provider Market Outlook, an 81-page assessment e-book of the technologies, vendors and operating capabilities expected to shape health IT investment across the region. Based on feedback from 684 provider-side leaders, the study concludes that Australia is entering one of its most active healthcare technology buying periods...

Read more

A Look Into the ALJ's Crystal Ball: What the DEA Marijuana Hearing Record May Be Telling Us

August 9, 2026 1:45 PM

No one outside the courtroom can know what Administrative Law Judge Derek C. Julius will ultimately recommend following the Drug Enforcement Administration's marijuana rescheduling hearing. But the hearing transcripts may provide a glimpse into the crystal ball. With post-hearing briefs due August 17, 2026, and an ALJ recommendation expected at some point thereafter, MMJ International Holdings says the testimony developed during the proceeding...

Read more

Holcomb-Kreithen Plastic Surgery & Medspa Named a 2026 Castle Connolly Practice Center of Excellence

August 9, 2026 9:00 AM

Holcomb-Kreithen Plastic Surgery & Medspa has been named a 2026 Castle Connolly Practice Center of Excellence, a designation that recognizes healthcare organizations where multiple physicians hold Castle Connolly Top Doctor recognition. This is an institution-level honor that reflects the collective surgical depth of a practice's team and a record of peer-validated clinical standards. The recognition carries particular weight in a field where...

Read more

ClearVue+ Reviews & Complaints 2026: Adults Serious About Long-Term Eye Wellness Discover the Lutein & Zeaxanthin Formula

August 8, 2026 4:05 PM

Quick disclosure: this is a paid advertorial, and a commission is earned if you purchase through links in this article. Product claims come from the brand and aren't independently endorsed here. ClearVue+ is a dietary supplement - not a drug, not FDA-approved, and not intended to diagnose, treat, cure, or prevent any disease, per the brand's own label. Official site: clearvueplus.com. ClearVue+ Reviews and Complaints: Legit Eye Supplement or...

Read more

Valiora Reviews & Complaints 2026: Metabolism Buyers Discover the Green Tea, ACV and Berberine Blend - But One Detail Is Driving Questions

August 8, 2026 3:10 PM

Quick disclosure: this is a paid advertorial, and a commission may be earned if you buy through the links here. Claims about Valiora come from the brand, not from independent testing - Valiora a dietary supplement, not a drug, and not FDA-approved. The brand's own site states, verbatim, that its claims "have not been evaluated by the Food and Drug Administration" and that the product isn't meant to diagnose, treat, cure or prevent disease. You...

Read more

CoreAge Rx GLP-1 Reviews 2026: Adults Ready to Get Serious About Weight Management Discover the Online GLP-1 Program

August 8, 2026 1:55 PM

Quick disclosure before you read further: This content is promotional in nature and is intended for consumer education regarding a commercially available product. It's a paid advertorial, and a commission is earned if you purchase through links in this article. Product claims are attributed to the brand and are not independently endorsed. CoreAge Rx offers compounded semaglutide and tirzepatide - these are not FDA-approved, and per the brand's...

Read more

Quiet Nerves Reviews & Complaints 2026: Adults Ready to Get Serious About Daily Nerve Comfort Discover the 6-Ingredient Formula

August 7, 2026 7:35 PM

Quick disclosure before you read further: This is a paid advertorial. If you purchase through links in this article, a commission may be earned at no additional cost to you. Product claims are attributed to the brand and are not independently endorsed. Quiet Nerves is a dietary supplement - not a drug, not FDA-approved, and per the brand's own disclaimer, not intended to diagnose, treat, cure, or prevent any disease. Title phrases including...

Read more

Something Is Rotten at CMS: Dr. Oz Demands FDA Approval - Then Defends a $500 Medicare Pathway for Unapproved Hemp Products

August 7, 2026 4:25 PM

MMJ International Holdings Took the Route Dr. Oz Described - Eight Years, $10 Million, and a Federal Application Still Undecided. Meanwhile CMS Placed Non-FDA-Approved Cannabinoid Products Into Physician-Directed Medicare Care. MMJ International Holdings agrees. The company has spent more than $10 million and nearly a decade doing precisely that. The difficulty is what the Administrator's own agency has built alongside it. The program CMS...

Read more

SS Support Network Expands U.S. Reach with Comprehensive BPO Services for Healthcare Providers

August 7, 2026 3:00 PM

SS Support Network LLC, a Vancouver, Washington-based healthcare BPO and call center, has expanded its services beyond non-emergency medical transportation (NEMT) to serve home care agencies, medical clinics, dental practices, behavioral health providers, hospice organizations and DME suppliers across the United States. The expanded portfolio includes 24/7 patient call handling, appointment scheduling, referral intake, insurance verification,...

Read more

Europe's Hospitals on Red Alert as Four Countries Enter the Critical Cyber-Risk Tier

August 7, 2026 2:10 PM

Black Book Research has released Europe's Healthcare Cybersecurity Hotspots 2026, an independent assessment of cybersecurity pressure across hospitals, health systems and public health agencies in 30 European countries. The European index identifies Poland, the United Kingdom, France and Germany in the critical risk-pressure tier, with nine additional countries classified as very high risk. The index measures the combined pressure created by...

Read more